Literature DB >> 26559402

Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma.

Judith L Hannon1, Gwen Clarke1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26559402     DOI： 10.1111/trf.13267

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

1.  Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.

Authors:  Willy A Flegel; Qing Chen; Lilian Castilho; Margaret A Keller; Ellen B Klapper; William J Lane; France Pirenne; Gary Stack; Maryse St-Louis; Christopher A Tormey; Dan A Waxman; Christof Weinstock; Silvano Wendel; Gregory A Denomme
Journal:  Blood Transfus       Date:  2018-02-14       Impact factor: 3.443

Review 2.  New developments in the treatment of multiple myeloma - clinical utility of daratumumab.

Authors:  Cian McEllistrim; Janusz Krawczyk; Michael E O'Dwyer
Journal:  Biologics       Date:  2017-04-11

3.  Transfusion management for patients taking an anti-CD38 monoclonal antibody.

Authors:  Carolina Bonet Bub; Isabel Nagle Dos Reis; Maria Giselda Aravechia; Leandro Dinalli Santos; Eduardo Peres Bastos; José Mauro Kutner; Lilian Castilho
Journal:  Rev Bras Hematol Hemoter       Date:  2017-11-26

Review 4.  Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab.

Authors:  Marilyn T Nedumcheril; Robert A DeSimone; Sabrina E Racine-Brzostek; Ok Kyong Chaekal; Ljiljana V Vasovic
Journal:  J Blood Med       Date:  2021-05-25

5.  Interference of daratumumab with pretransfusion testing, mimicking a high-titer, low avidity like antibody.

Authors:  Mei-Hwa Lin; Fei-Yun Liu; Hsiu-Mien Wang; Hsin-Ching Cho; Shyh-Chyi Lo
Journal:  Asian J Transfus Sci       Date:  2017 Jul-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.